Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:glycopyrrolate
|
| gptkbp:activities |
reduces saliva production
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:clinical_trial |
pediatric patients
adult patients NC T02012345 NC T02212345 NC T01812345 |
| gptkbp:contraindication |
gptkb:sneaker
gptkb:Insurance_Company urinary obstruction severe ulcerative colitis |
| gptkbp:dosage_form |
gptkb:item
based on weight |
| gptkbp:formulation |
oral solution
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cuvposa
|
| gptkbp:indication |
sialorrhea
|
| gptkbp:ingredients |
gptkb:glycopyrrolate
|
| gptkbp:interacts_with |
antihistamines
antidepressants opioids muscle relaxants other anticholinergic drugs |
| gptkbp:invention |
gptkb:Shionogi_Inc.
|
| gptkbp:is_used_for |
treatment of excessive salivation
|
| gptkbp:label |
contains preservatives
contains sugar contains alcohol contains artificial flavoring |
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Shionogi_Inc.
|
| gptkbp:marketed_as |
gptkb:2013
|
| gptkbp:packaging |
gptkb:beer
|
| gptkbp:pharmacokinetics |
anticholinergic agent
|
| gptkbp:population |
consult healthcare provider before use
keep out of reach of children do not exceed recommended dose store in original container report any side effects |
| gptkbp:safety_features |
not recommended for children under 3 years
|
| gptkbp:side_effect |
dizziness
fatigue headache nausea allergic reactions vomiting confusion seizures dry skin insomnia constipation difficulty swallowing dry mouth nervousness blurred vision hallucinations increased heart rate thirst urinary retention |
| gptkbp:storage |
room temperature
|